Quadruple therapy for Helicobacter pylori infection reply

被引：1
|
作者：
Liou, Jyh-Ming [1 ,2 ]
Lee, Yi-Chia [1 ,2 ]
Wu, Ming-Shiang [1 ]
机构：
[1] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan
来源：
LANCET | 2013年 / 381卷 / 9876期
关键词：
TRIPLE THERAPY; METAANALYSIS; ERADICATION;
D O I：
10.1016/S0140-6736(13)60926-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1459 / 1460
页数：4
相关论文
共 50 条
  • [31] Helicobacter pylori infection: an overview in 2013, focus on therapy
    Cui Rongli
    Zhou Liya
    CHINESE MEDICAL JOURNAL, 2014, 127 (03) : 568 - 573
  • [32] Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylere®) for Helicobacter pylori eradication
    Castro-Fernandez, Manuel
    Marques-Ruiz, Alberto
    Camara-Baena, Sergio
    Grande-Santamaria, Lourdes
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (07): : 459 - 460
  • [33] Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
    Bacaksiz, Elif Gram
    Hakim, Gozde Dervis
    Yildiz, Coskun
    Akar, Harun
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2022, 17 (02): : 138 - 145
  • [34] Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance
    Zheng, Qing
    Chen, Wan Jun
    Lu, Hong
    Sun, Qin Juan
    Xiao, Shu Dong
    JOURNAL OF DIGESTIVE DISEASES, 2010, 11 (05) : 313 - 318
  • [35] Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infection
    Pih, Gyu Young
    Choi, Kee Don
    Gong, Eun Jeong
    Na, Hee Kyong
    Ahn, Ji Yong
    Lee, Jeong Hoon
    Jung, Kee Wook
    Kim, Do Hoon
    Song, Ho June
    Lee, Gin Hyug
    Jung, Hwoon-Yong
    HELICOBACTER, 2021, 26 (01)
  • [36] Helicobacter Pylori Infection
    Fischbach, Wolfgang
    Malfertheiner, Peter
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (25): : 429 - 436
  • [37] Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis
    Shen, Huili
    Chen, Yijie
    Li, Xiaohui
    Yan, Jing
    Zhao, Junjie
    Kong, Demin
    Shi, Yanxia
    Li, Zhihui
    Wang, Jihong
    Shao, Na
    Wang, Zhenghui
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [38] Response to: Reply on "Renewed Helicobacter pylori management and therapy in 2015"
    Fagoonee, Sharmila
    Pellicano, Rinaldo
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (01) : 81 - 81
  • [39] Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection
    Ji Hyun Lim
    Dong Ho Lee
    Seong Tae Lee
    Nayoung Kim
    Young Soo Park
    Cheol Min Shin
    In Sung Song
    World Journal of Gastroenterology, 2015, (46) : 13124 - 13131
  • [40] Letter: levofloxacin resistance - a challenge for treatment of Helicobacter pylori infection. Authors' reply
    Chen, P. -Y.
    Wu, M. -S.
    Liou, J. -M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 573 - 573
12345